India reported almost 45 million cases of the coronavirus (COVID-19) as of October 20, 2023, with more than 44 million recoveries and about 532 thousand fatalities. The number of cases in the country had a decreasing trend in the past months.

Burden on the healthcare system

With the world's second largest population in addition to an even worse second wave of the coronavirus pandemic seems to be crushing an already inadequate healthcare system. Despite vast numbers being vaccinated, a new variant seemed to be affecting younger age groups this time around. The lack of ICU beds, black market sales of oxygen cylinders and drugs needed to treat COVID-19, as well as overworked crematoriums resorting to mass burials added to the woes of the country. Foreign aid was promised from various countries including the United States, France, Germany and the United Kingdom. Additionally, funding from the central government was expected to boost vaccine production.

Situation overview
Even though days in April 2021 saw record-breaking numbers compared to any other country worldwide, a nation-wide lockdown has not been implemented. The largest religious gathering - the Kumbh Mela, sacred to the Hindus, along with election rallies in certain states continue to be held. Some states and union territories including Maharashtra, Delhi, and Karnataka had issued curfews and lockdowns to try to curb the spread of infections.

India recorded 29427330 Coronavirus Recovered since the epidemic began, according to the World Health Organization (WHO). In addition, India reported 476135 Coronavirus Deaths. This dataset includes a chart with historical data for India Coronavirus Recovered.

India reported over 44 million confirmed cases of the coronavirus (COVID-19) as of October 20, 2023. The number of people infected with the virus was declining across the south Asian country.

What is the coronavirus?

COVID-19 is part of a large family of coronaviruses (CoV) that are transmitted from animals to people. The name COVID-19 is derived from the words corona, virus, and disease, while the number 19 represents the year that it emerged. Symptoms of COVID-19 resemble that of the common cold, with fever, coughing, and shortness of breath. However, serious infections can lead to pneumonia, multi-organ failure, severe acute respiratory syndrome, and even death, if appropriate medical help is not provided.

COVID-19 in India

India reported its first case of this coronavirus in late January 2020 in the southern state of Kerala. That led to a nation-wide lockdown between March and June that year to curb numbers from rising. After marginal success, the economy opened up leading to some recovery for the rest of 2020. In March 2021, however, the second wave hit the country causing record-breaking numbers of infections and deaths, crushing the healthcare system. The central government has been criticized for not taking action this time around, with "#ResignModi" trending on social media platforms in late April. The government's response was to block this line of content on the basis of fighting misinformation and reducing panic across the country.

Maharashtra confirmed over 8.1 million cases of the coronavirus (COVID-19) as of October 20, 2023, with over 148 thousand fatalities and over eight million recoveries. A state-wide lockdown was implemented in late April 2021 to attempt reducing infections and deaths.

The number of COVID-19 vaccination doses administered in India rose to 2206672631 as of Oct 27 2023. This dataset includes a chart with historical data for India Coronavirus Vaccination Total.

The number of COVID-19 vaccination doses administered per 100 people in India rose to 156 as of Oct 27 2023. This dataset includes a chart with historical data for India Coronavirus Vaccination Rate.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

This dataset provides values for CORONAVIRUS DEATHS reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

The impact of the coronavirus (COVID-19) pandemic had not only brought the global economy to a standstill but set the clock backwards on the developmental progress of several nations. While the rate of infection in India did not appear to be as high as in other countries, precautionary measures adopted dealt a severe blow to the country’s major industries - with the service sector bearing the largest brunt of estimated loss. Manufacturing made a swift recovery in the following months.

Impact of key industries

The loss incurred by enforcing a lockdown in the country was estimated at 26 billion U.S. dollars and a significant decline in GDP growth is also expected in the June quarter of 2020. With the imposition of restrictions on transportation worldwide, the trade sector also took a hit. Exports and imports saw a drastic decline in the country especially in the case of essential commodities such as petroleum, food crops, and coal, among others.

Effect on business in India

The growth rate of the automotive business in India was expected to be the most adversely affected followed by the power supply and IT sectors. Furthermore, many startups, small and medium enterprises in India expected to face issues of supply disruption and a decrease in demand. The effects of aid from the Narendra Modi-led government arguably did little to help in the face of a faltering economy.

The outbreak of the novel coronavirus in Wuhan, China, saw infection cases spread throughout the Asia-Pacific region. By April 13, 2024, India had faced over 45 million coronavirus cases. South Korea followed behind India as having had the second highest number of coronavirus cases in the Asia-Pacific region, with about 34.6 million cases. At the same time, Japan had almost 34 million cases. At the beginning of the outbreak, people in South Korea had been optimistic and predicted that the number of cases would start to stabilize. What is SARS CoV 2?Novel coronavirus, officially known as SARS CoV 2, is a disease which causes respiratory problems which can lead to difficulty breathing and pneumonia. The illness is similar to that of SARS which spread throughout China in 2003. After the outbreak of the coronavirus, various businesses and shops closed to prevent further spread of the disease. Impacts from flight cancellations and travel plans were felt across the Asia-Pacific region. Many people expressed feelings of anxiety as to how the virus would progress. Impact throughout Asia-PacificThe Coronavirus and its variants have affected the Asia-Pacific region in various ways. Out of all Asia-Pacific countries, India was highly affected by the pandemic and experienced more than 50 thousand deaths. However, the country also saw the highest number of recoveries within the APAC region, followed by South Korea and Japan.

Dataset general description:

• This dataset reports 4195 recurrent neural network models, their settings, and their generated prediction csv files, graphs, and metadata files, for predicting COVID-19's daily infections in Brazil by training on limited raw data (30 time-steps and 40 time-steps alternatives). The used code is developed by the author and located in the following online data repository link: http://dx.doi.org/10.17632/yp4d95pk7n.1

Dataset content:

• Models, Graphs, and csv predictions files: 1. Deterministic mode (DM): includes 1194 generated models files (30 time-steps), and their generated 2835 graphs and 2835 predictions files. Similarly, this mode includes 1976 generated model files (40 time-steps), and their generated 7301 graphs and 7301 predictions files. 2. Non-deterministic mode (NDM): includes 20 generated model files (30 time-steps), and their generated 53 graphs and 53 predictions files. 3. Technical validation mode (TVM): includes 1001 generated model files (30 time-steps), and their generated 3619 graphs and 3619 predictions files for 358 models, which are a sample of 1001 models. Also, 1 model in control group for India. 4. 1 graph and 1 prediction files for each of DM and NDM, reporting evaluation till 2020-07-11.

• Settings and metadata for the above 3 categories: 1. Used settings in json files for reproducibility. 2. Metadata about training and prediction setup and accuracy in csv files.

Raw data source that was used to train the models:

• The used raw data for training the models is from: COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University): https://github.com/CSSEGISandData/COVID-19

• The models were trained on these versions of the raw data: 1. Link till 2020-06-29 (accessed 2020-07-08): https://github.com/CSSEGISandData/COVID-19/raw/78d91b2dbc2a26eb2b2101fa499c6798aa22fca8/csse_covid_19_data/csse_covid_19_time_series/time_series_covid19_confirmed_global.csv 2. Link till 2020-06-13 (accessed 2020-07-08): https://github.com/CSSEGISandData/COVID-19/raw/02ea750a263f6d8b8945fdd3253b35d3fd9b1bee/csse_covid_19_data/csse_covid_19_time_series/time_series_covid19_confirmed_global.csv

License: This prediction Dataset is licensed under CC BY NC 3.0.

Notice and disclaimer: 1- This prediction Dataset is for scientific and research purposes only. 2- The generation of this Dataset complies with the terms of use of the publicly available raw data from the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University: https://github.com/CSSEGISandData/COVID-19 and therefore, the author of the prediction Dataset disclaims any and all responsibility and warranties regarding the contents of used raw data, including but not limited to: the correctness, completeness, and any issues linked to third-party rights.

Delhi confirmed almost two million cases of the coronavirus (COVID-19) as of October 20, 2023, with over 26 thousand fatalities and over two million recoveries. The Delhi government, led by Arvind Kejriwal and the Aam Aadmi Party implemented a night and weekend curfew to curb infection numbers in late April 2021. The capital region faced acute shortage of oxygen and ICU beds during this time period.

To create the dataset, the top 10 countries leading in the incidence of COVID-19 in the world were selected as of October 22, 2020 (on the eve of the second full of pandemics), which are presented in the Global 500 ranking for 2020: USA, India, Brazil, Russia, Spain, France and Mexico. For each of these countries, no more than 10 of the largest transnational corporations included in the Global 500 rating for 2020 and 2019 were selected separately. The arithmetic averages were calculated and the change (increase) in indicators such as profitability and profitability of enterprises, their ranking position (competitiveness), asset value and number of employees. The arithmetic mean values of these indicators for all countries of the sample were found, characterizing the situation in international entrepreneurship as a whole in the context of the COVID-19 crisis in 2020 on the eve of the second wave of the pandemic. The data is collected in a general Microsoft Excel table. Dataset is a unique database that combines COVID-19 statistics and entrepreneurship statistics. The dataset is flexible data that can be supplemented with data from other countries and newer statistics on the COVID-19 pandemic. Due to the fact that the data in the dataset are not ready-made numbers, but formulas, when adding and / or changing the values in the original table at the beginning of the dataset, most of the subsequent tables will be automatically recalculated and the graphs will be updated. This allows the dataset to be used not just as an array of data, but as an analytical tool for automating scientific research on the impact of the COVID-19 pandemic and crisis on international entrepreneurship. The dataset includes not only tabular data, but also charts that provide data visualization. The dataset contains not only actual, but also forecast data on morbidity and mortality from COVID-19 for the period of the second wave of the pandemic in 2020. The forecasts are presented in the form of a normal distribution of predicted values and the probability of their occurrence in practice. This allows for a broad scenario analysis of the impact of the COVID-19 pandemic and crisis on international entrepreneurship, substituting various predicted morbidity and mortality rates in risk assessment tables and obtaining automatically calculated consequences (changes) on the characteristics of international entrepreneurship. It is also possible to substitute the actual values identified in the process and following the results of the second wave of the pandemic to check the reliability of pre-made forecasts and conduct a plan-fact analysis. The dataset contains not only the numerical values of the initial and predicted values of the set of studied indicators, but also their qualitative interpretation, reflecting the presence and level of risks of a pandemic and COVID-19 crisis for international entrepreneurship.

This dataset includes CSV files that contain IDs and sentiment scores of the tweets related to the COVID-19 pandemic. The tweets have been collected by an on-going project deployed at https://live.rlamsal.com.np. The model monitors the real-time Twitter feed for coronavirus-related tweets using 90+ different keywords and hashtags that are commonly used while referencing the pandemic. This dataset has been wholly re-designed on March 20, 2020, to comply with the content redistribution policy set by Twitter.The paper associated with this dataset is available here: Design and analysis of a large-scale COVID-19 tweets dataset-------------------------------------Related datasets:(a) Tweets Originating from India During COVID-19 Lockdowns(b) Coronavirus (COVID-19) Tweets Sentiment Trend (Global)-------------------------------------Below is the quick overview of this dataset.— Dataset name: COV19Tweets Dataset— Number of tweets : 857,809,018 tweets— Coverage : Global— Language : English (EN)— Dataset usage terms : By using this dataset, you agree to (i) use the content of this dataset and the data generated from the content of this dataset for non-commercial research only, (ii) remain in compliance with Twitter's Developer Policy and (iii) cite the following paper:Lamsal, R. Design and analysis of a large-scale COVID-19 tweets dataset. Applied Intelligence (2020). https://doi.org/10.1007/s10489-020-02029-z— Geo-tagged Version: Coronavirus (COVID-19) Geo-tagged Tweets Dataset (GeoCOV19Tweets Dataset)— Dataset updates : Everyday— Active keywords and hashtags (archive: keywords.tsv) : "corona", "#corona", "coronavirus", "#coronavirus", "covid", "#covid", "covid19", "#covid19", "covid-19", "#covid-19", "sarscov2", "#sarscov2", "sars cov2", "sars cov 2", "covid_19", "#covid_19", "#ncov", "ncov", "#ncov2019", "ncov2019", "2019-ncov", "#2019-ncov", "pandemic", "#pandemic" "#2019ncov", "2019ncov", "quarantine", "#quarantine", "flatten the curve", "flattening the curve", "#flatteningthecurve", "#flattenthecurve", "hand sanitizer", "#handsanitizer", "#lockdown", "lockdown", "social distancing", "#socialdistancing", "work from home", "#workfromhome", "working from home", "#workingfromhome", "ppe", "n95", "#ppe", "#n95", "#covidiots", "covidiots", "herd immunity", "#herdimmunity", "pneumonia", "#pneumonia", "chinese virus", "#chinesevirus", "wuhan virus", "#wuhanvirus", "kung flu", "#kungflu", "wearamask", "#wearamask", "wear a mask", "vaccine", "vaccines", "#vaccine", "#vaccines", "corona vaccine", "corona vaccines", "#coronavaccine", "#coronavaccines", "face shield", "#faceshield", "face shields", "#faceshields", "health worker", "#healthworker", "health workers", "#healthworkers", "#stayhomestaysafe", "#coronaupdate", "#frontlineheroes", "#coronawarriors", "#homeschool", "#homeschooling", "#hometasking", "#masks4all", "#wfh", "wash ur hands", "wash your hands", "#washurhands", "#washyourhands", "#stayathome", "#stayhome", "#selfisolating", "self isolating"Dataset Files (the local time mentioned below is GMT+5:45)corona_tweets_01.csv + corona_tweets_02.csv + corona_tweets_03.csv: 2,475,980 tweets (March 20, 2020 01:37 AM - March 21, 2020 09:25 AM)corona_tweets_04.csv: 1,233,340 tweets (March 21, 2020 09:27 AM - March 22, 2020 07:46 AM)corona_tweets_05.csv: 1,782,157 tweets (March 22, 2020 07:50 AM - March 23, 2020 09:08 AM)corona_tweets_06.csv: 1,771,295 tweets (March 23, 2020 09:11 AM - March 24, 2020 11:35 AM)corona_tweets_07.csv: 1,479,651 tweets (March 24, 2020 11:42 AM - March 25, 2020 11:43 AM)corona_tweets_08.csv: 1,272,592 tweets (March 25, 2020 11:47 AM - March 26, 2020 12:46 PM)corona_tweets_09.csv: 1,091,429 tweets (March 26, 2020 12:51 PM - March 27, 2020 11:53 AM)corona_tweets_10.csv: 1,172,013 tweets (March 27, 2020 11:56 AM - March 28, 2020 01:59 PM)corona_tweets_11.csv: 1,141,210 tweets (March 28, 2020 02:03 PM - March 29, 2020 04:01 PM)corona_tweets_12.csv: 793,417 tweets (March 30, 2020 02:01 PM - March 31, 2020 10:16 AM)corona_tweets_13.csv: 1,029,294 tweets (March 31, 2020 10:20 AM - April 01, 2020 10:59 AM)corona_tweets_14.csv: 920,076 tweets (April 01, 2020 11:02 AM - April 02, 2020 12:19 PM)corona_tweets_15.csv: 826,271 tweets (April 02, 2020 12:21 PM - April 03, 2020 02:38 PM)corona_tweets_16.csv: 612,512 tweets (April 03, 2020 02:40 PM - April 04, 2020 11:54 AM)corona_tweets_17.csv: 685,560 tweets (April 04, 2020 11:56 AM - April 05, 2020 12:54 PM)corona_tweets_18.csv: 717,301 tweets (April 05, 2020 12:56 PM - April 06, 2020 10:57 AM)corona_tweets_19.csv: 722,921 tweets (April 06, 2020 10:58 AM - April 07, 2020 12:28 PM)corona_tweets_20.csv: 554,012 tweets (April 07, 2020 12:29 PM - April 08, 2020 12:34 PM)corona_tweets_21.csv: 589,679 tweets (April 08, 2020 12:37 PM - April 09, 2020 12:18 PM)corona_tweets_22.csv: 517,718 tweets (April 09, 2020 12:20 PM - April 10, 2020 09:20 AM)corona_tweets_23.csv: 601,199 tweets (April 10, 2020 09:22 AM - April 11, 2020 10:22 AM)corona_tweets_24.csv: 497,655 tweets (April 11, 2020 10:24 AM - April 12, 2020 10:53 AM)corona_tweets_25.csv: 477,182 tweets (April 12, 2020 10:57 AM - April 13, 2020 11:43 AM)corona_tweets_26.csv: 288,277 tweets (April 13, 2020 11:46 AM - April 14, 2020 12:49 AM)corona_tweets_27.csv: 515,739 tweets (April 14, 2020 11:09 AM - April 15, 2020 12:38 PM)corona_tweets_28.csv: 427,088 tweets (April 15, 2020 12:40 PM - April 16, 2020 10:03 AM)corona_tweets_29.csv: 433,368 tweets (April 16, 2020 10:04 AM - April 17, 2020 10:38 AM)corona_tweets_30.csv: 392,847 tweets (April 17, 2020 10:40 AM - April 18, 2020 10:17 AM)> With the addition of some more coronavirus specific keywords, the number of tweets captured day has increased significantly, therefore, the CSV files hereafter will be zipped. Lets save some bandwidth.corona_tweets_31.csv: 2,671,818 tweets (April 18, 2020 10:19 AM - April 19, 2020 09:34 AM)corona_tweets_32.csv: 2,393,006 tweets (April 19, 2020 09:43 AM - April 20, 2020 10:45 AM)corona_tweets_33.csv: 2,227,579 tweets (April 20, 2020 10:56 AM - April 21, 2020 10:47 AM)corona_tweets_34.csv: 2,211,689 tweets (April 21, 2020 10:54 AM - April 22, 2020 10:33 AM)corona_tweets_35.csv: 2,265,189 tweets (April 22, 2020 10:45 AM - April 23, 2020 10:49 AM)corona_tweets_36.csv: 2,201,138 tweets (April 23, 2020 11:08 AM - April 24, 2020 10:39 AM)corona_tweets_37.csv: 2,338,713 tweets (April 24, 2020 10:51 AM - April 25, 2020 11:50 AM)corona_tweets_38.csv: 1,981,835 tweets (April 25, 2020 12:20 PM - April 26, 2020 09:13 AM)corona_tweets_39.csv: 2,348,827 tweets (April 26, 2020 09:16 AM - April 27, 2020 10:21 AM)corona_tweets_40.csv: 2,212,216 tweets (April 27, 2020 10:33 AM - April 28, 2020 10:09 AM)corona_tweets_41.csv: 2,118,853 tweets (April 28, 2020 10:20 AM - April 29, 2020 08:48 AM)corona_tweets_42.csv: 2,390,703 tweets (April 29, 2020 09:09 AM - April 30, 2020 10:33 AM)corona_tweets_43.csv: 2,184,439 tweets (April 30, 2020 10:53 AM - May 01, 2020 10:18 AM)corona_tweets_44.csv: 2,223,013 tweets (May 01, 2020 10:23 AM - May 02, 2020 09:54 AM)corona_tweets_45.csv: 2,216,553 tweets (May 02, 2020 10:18 AM - May 03, 2020 09:57 AM)corona_tweets_46.csv: 2,266,373 tweets (May 03, 2020 10:09 AM - May 04, 2020 10:17 AM)corona_tweets_47.csv: 2,227,489 tweets (May 04, 2020 10:32 AM - May 05, 2020 10:17 AM)corona_tweets_48.csv: 2,218,774 tweets (May 05, 2020 10:38 AM - May 06, 2020 10:26 AM)corona_tweets_49.csv: 2,164,251 tweets (May 06, 2020 10:35 AM - May 07, 2020 09:33 AM)corona_tweets_50.csv: 2,203,686 tweets (May 07, 2020 09:55 AM - May 08, 2020 09:35 AM)corona_tweets_51.csv: 2,250,019 tweets (May 08, 2020 09:39 AM - May 09, 2020 09:49 AM)corona_tweets_52.csv: 2,273,705 tweets (May 09, 2020 09:55 AM - May 10, 2020 10:11 AM)corona_tweets_53.csv: 2,208,264 tweets (May 10, 2020 10:23 AM - May 11, 2020 09:57 AM)corona_tweets_54.csv: 2,216,845 tweets (May 11, 2020 10:08 AM - May 12, 2020 09:52 AM)corona_tweets_55.csv: 2,264,472 tweets (May 12, 2020 09:59 AM - May 13, 2020 10:14 AM)corona_tweets_56.csv: 2,339,709 tweets (May 13, 2020 10:24 AM - May 14, 2020 11:21 AM)corona_tweets_57.csv: 2,096,878 tweets (May 14, 2020 11:38 AM - May 15, 2020 09:58 AM)corona_tweets_58.csv: 2,214,205 tweets (May 15, 2020 10:13 AM - May 16, 2020 09:43 AM)> The server and the databases have been optimized; therefore, there is a significant rise in the number of tweets captured per day.corona_tweets_59.csv: 3,389,090 tweets (May 16, 2020 09:58 AM - May 17, 2020 10:34 AM)corona_tweets_60.csv: 3,530,933 tweets (May 17, 2020 10:36 AM - May 18, 2020 10:07 AM)corona_tweets_61.csv: 3,899,631 tweets (May 18, 2020 10:08 AM - May 19, 2020 10:07 AM)corona_tweets_62.csv: 3,767,009 tweets (May 19, 2020 10:08 AM - May 20, 2020 10:06 AM)corona_tweets_63.csv: 3,790,455 tweets (May 20, 2020 10:06 AM - May 21, 2020 10:15 AM)corona_tweets_64.csv: 3,582,020 tweets (May 21, 2020 10:16 AM - May 22, 2020 10:13 AM)corona_tweets_65.csv: 3,461,470 tweets (May 22, 2020 10:14 AM - May 23, 2020 10:08 AM)corona_tweets_66.csv: 3,477,564 tweets (May 23, 2020 10:08 AM - May 24, 2020 10:02 AM)corona_tweets_67.csv: 3,656,446 tweets (May 24, 2020 10:02 AM - May 25, 2020 10:10 AM)corona_tweets_68.csv: 3,474,952 tweets (May 25, 2020 10:11 AM - May 26, 2020 10:22 AM)corona_tweets_69.csv: 3,422,960 tweets (May 26, 2020 10:22 AM - May 27, 2020 10:16 AM)corona_tweets_70.csv: 3,480,999 tweets (May 27, 2020 10:17 AM - May 28, 2020 10:35 AM)corona_tweets_71.csv: 3,446,008 tweets (May 28, 2020 10:36 AM - May 29, 2020 10:07 AM)corona_tweets_72.csv: 3,492,841 tweets (May 29, 2020 10:07 AM - May 30, 2020 10:14 AM)corona_tweets_73.csv: 3,098,817 tweets (May 30, 2020 10:15 AM - May 31, 2020 10:13 AM)corona_tweets_74.csv: 3,234,848 tweets (May 31, 2020 10:13 AM - June 01, 2020 10:14 AM)corona_tweets_75.csv: 3,206,132 tweets (June 01, 2020 10:15 AM - June 02, 2020 10:07 AM)corona_tweets_76.csv: 3,206,417 tweets (June 02, 2020 10:08 AM - June 03, 2020 10:26 AM)corona_tweets_77.csv: 3,256,225 tweets (June 03, 2020

On March 10, 2023, the Johns Hopkins Coronavirus Resource Center ceased its collecting and reporting of global COVID-19 data. For updated cases, deaths, and vaccine data please visit the following sources: World Health Organization (WHO)For more information, visit the Johns Hopkins Coronavirus Resource Center.-- Esri COVID-19 Trend Report for 3-9-2023 --0 Countries have Emergent trend with more than 10 days of cases: (name : # of active cases) 41 Countries have Spreading trend with over 21 days in new cases curve tail: (name : # of active cases)Monaco : 13, Andorra : 25, Marshall Islands : 52, Kyrgyzstan : 79, Cuba : 82, Saint Lucia : 127, Cote d'Ivoire : 148, Albania : 155, Bosnia and Herzegovina : 172, Iceland : 196, Mali : 198, Suriname : 246, Botswana : 247, Barbados : 274, Dominican Republic : 304, Malta : 306, Venezuela : 334, Micronesia : 346, Uzbekistan : 356, Afghanistan : 371, Jamaica : 390, Latvia : 402, Mozambique : 406, Kosovo : 412, Azerbaijan : 427, Tunisia : 528, Armenia : 594, Kuwait : 716, Thailand : 746, Norway : 768, Croatia : 847, Honduras : 1002, Zimbabwe : 1067, Saudi Arabia : 1098, Bulgaria : 1148, Zambia : 1166, Panama : 1300, Uruguay : 1483, Kazakhstan : 1671, Paraguay : 2080, Ecuador : 53320 Countries may have Spreading trend with under 21 days in new cases curve tail: (name : # of active cases)61 Countries have Epidemic trend with over 21 days in new cases curve tail: (name : # of active cases)Liechtenstein : 48, San Marino : 111, Mauritius : 742, Estonia : 761, Trinidad and Tobago : 1296, Montenegro : 1486, Luxembourg : 1540, Qatar : 1541, Philippines : 1915, Ireland : 1946, Brunei : 2010, United Arab Emirates : 2013, Denmark : 2111, Sweden : 2149, Finland : 2154, Hungary : 2169, Lebanon : 2208, Bolivia : 2838, Colombia : 3250, Switzerland : 3321, Peru : 3328, Slovakia : 3556, Malaysia : 3608, Indonesia : 3793, Portugal : 4049, Cyprus : 4279, Argentina : 5050, Iran : 5135, Lithuania : 5323, Guatemala : 5516, Slovenia : 5689, South Africa : 6604, Georgia : 7938, Moldova : 8082, Israel : 8746, Bahrain : 8932, Netherlands : 9710, Romania : 12375, Costa Rica : 12625, Singapore : 13816, Serbia : 14093, Czechia : 14897, Spain : 17399, Ukraine : 19568, Canada : 24913, New Zealand : 25136, Belgium : 30599, Poland : 38894, Chile : 41055, Australia : 50192, Mexico : 65453, United Kingdom : 65697, France : 68318, Italy : 70391, Austria : 90483, Brazil : 134279, Korea - South : 209145, Russia : 214935, Germany : 257248, Japan : 361884, US : 6440500 Countries may have Epidemic trend with under 21 days in new cases curve tail: (name : # of active cases) 54 Countries have Controlled trend: (name : # of active cases)Palau : 3, Saint Kitts and Nevis : 4, Guinea-Bissau : 7, Cabo Verde : 8, Mongolia : 8, Benin : 9, Maldives : 10, Comoros : 10, Gambia : 12, Bhutan : 14, Cambodia : 14, Syria : 14, Seychelles : 15, Senegal : 16, Libya : 16, Laos : 17, Sri Lanka : 19, Congo (Brazzaville) : 19, Tonga : 21, Liberia : 24, Chad : 25, Fiji : 26, Nepal : 27, Togo : 30, Nicaragua : 32, Madagascar : 37, Sudan : 38, Papua New Guinea : 38, Belize : 59, Egypt : 60, Algeria : 64, Burma : 65, Ghana : 72, Haiti : 74, Eswatini : 75, Guyana : 79, Rwanda : 83, Uganda : 88, Kenya : 92, Burundi : 94, Angola : 98, Congo (Kinshasa) : 125, Morocco : 125, Bangladesh : 127, Tanzania : 128, Nigeria : 135, Malawi : 148, Ethiopia : 248, Vietnam : 269, Namibia : 422, Cameroon : 462, Pakistan : 660, India : 4290 41 Countries have End Stage trend: (name : # of active cases)Sao Tome and Principe : 1, Saint Vincent and the Grenadines : 2, Somalia : 2, Timor-Leste : 2, Kiribati : 8, Mauritania : 12, Oman : 14, Equatorial Guinea : 20, Guinea : 28, Burkina Faso : 32, North Macedonia : 351, Nauru : 479, Samoa : 554, China : 2897, Taiwan* : 249634 -- SPIKING OF NEW CASE COUNTS --20 countries are currently experiencing spikes in new confirmed cases:Armenia, Barbados, Belgium, Brunei, Chile, Costa Rica, Georgia, India, Indonesia, Ireland, Israel, Kuwait, Luxembourg, Malaysia, Mauritius, Portugal, Sweden, Ukraine, United Kingdom, Uzbekistan 20 countries experienced a spike in new confirmed cases 3 to 5 days ago: Argentina, Bulgaria, Croatia, Czechia, Denmark, Estonia, France, Korea - South, Lithuania, Mozambique, New Zealand, Panama, Poland, Qatar, Romania, Slovakia, Slovenia, Switzerland, Trinidad and Tobago, United Arab Emirates 47 countries experienced a spike in new confirmed cases 5 to 14 days ago: Australia, Austria, Bahrain, Bolivia, Brazil, Canada, Colombia, Congo (Kinshasa), Cyprus, Dominican Republic, Ecuador, Finland, Germany, Guatemala, Honduras, Hungary, Iran, Italy, Jamaica, Japan, Kazakhstan, Lebanon, Malta, Mexico, Micronesia, Moldova, Montenegro, Netherlands, Nigeria, Pakistan, Paraguay, Peru, Philippines, Russia, Saint Lucia, Saudi Arabia, Serbia, Singapore, South Africa, Spain, Suriname, Thailand, Tunisia, US, Uruguay, Zambia, Zimbabwe 194 countries experienced a spike in new confirmed cases over 14 days ago: Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burma, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo (Brazzaville), Congo (Kinshasa), Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czechia, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Korea - South, Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, North Macedonia, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Switzerland, Syria, Taiwan*, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Tuvalu, US, Uganda, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, West Bank and Gaza, Yemen, Zambia, Zimbabwe Strongest spike in past two days was in US at 64,861 new cases.Strongest spike in past five days was in US at 64,861 new cases.Strongest spike in outbreak was 424 days ago in US at 1,354,505 new cases. Global Total Confirmed COVID-19 Case Rate of 8620.91 per 100,000Global Active Confirmed COVID-19 Case Rate of 37.24 per 100,000Global COVID-19 Mortality Rate of 87.69 per 100,000 21 countries with over 200 per 100,000 active cases.5 countries with over 500 per 100,000 active cases.3 countries with over 1,000 per 100,000 active cases.1 country with over 2,000 per 100,000 active cases.Nauru is worst at 4,354.54 per 100,000.

As global communities responded to COVID-19, we heard from public health officials that the same type of aggregated, anonymized insights we use in products such as Google Maps would be helpful as they made critical decisions to combat COVID-19. These Community Mobility Reports aimed to provide insights into what changed in response to policies aimed at combating COVID-19. The reports charted movement trends over time by geography, across different categories of places such as retail and recreation, groceries and pharmacies, parks, transit stations, workplaces, and residential.

COrona VIrus Disease (COVID) 2019 pandemic forced most countries to go into complete lockdown and India went on complete lockdown from 24th March 2020 to 8th June 2020. To understand the possible implications of lockdown, we analyze the long-term distribution of Net Primary Productivity (NPP) in the North Indian Ocean (NIO) and the factors that influence NPP directly and indirectly, for the period 2003–2019 and 2020 separately. There exists a seasonal cycle in the relationship between Aerosol Optical Depth (AOD), Chlorophyll-a (Chl-a) and NPP in agreement with the seasonal transport of aerosols and dust into these oceanic regions. In Arabian Sea (AS), the highest Chl-a (0.58 mg/m3), NPP (696.57 mg/C/m2/day) and AOD (0.39) are observed in June, July, August, and September (JJAS). Similarly, maximum Chl-a (0.48 mg/m3) and NPP (486.39 mg/C/m2/day) are found in JJAS and AOD (0.27) in March, April, and May (MAM) in Bay of Bengal. The interannual variability of Chl-a and NPP with wind speed and Sea Surface Temperature (SST) is also examined, where the former has a positive and the latter has a negative feedback to NPP. The interannual variability of NPP reveals a decreasing trend in NPP, which is interlinked with the increasing trend in SST and AOD. The analysis of wind, SST, Chl-a, and AOD for the pre-lockdown, lockdown, and post lockdown periods of 2020 is employed to understand the impact of COVID-19 lockdown on NPP. The assessment shows the reduction in AOD, decreased wind speeds, increased SST and reduced NPP during the lockdown period as compared to the pre-lockdown, post-lockdown and climatology. This analysis is expected to help to understand the impact of aerosols on the ocean biogeochemistry, nutrient cycles in the ocean biogeochemical models, and to study the effects of climate change on ocean ecosystems.

IntroductionLarge-scale sero-prevalence studies with representation from all age groups are required to estimate the true burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the community. Serial serological surveys in fixed cohorts enable study of dynamics of viral transmission and correlates of immune response over time in the context of gradual introduction of COVID-19 vaccines and repeated upsurge of cases during the pandemic.MethodsThis longitudinal study will involve follow-up of a cohort of 25,000 individuals (5,000 per site) aged 2 years and above recruited from five existing demographic surveillance sites in India. The cohort will be tested for the presence of IgG antibodies against S1/S2 spike protein subunits of SARS-CoV-2 in four rounds; once at baseline and subsequently, at intervals of 4 months for a year between January 2021 and January 2022. Neutralization assays will be carried out in a subset of seropositive samples in each round to quantify the antibody response and to estimate the durability of antibody response. Serial serological surveys will be complemented by fortnightly phone based syndromic surveillance to assess the burden of symptomatic acute febrile illness/ influenza like illness in the same cohort. A bio-repository will also be established to store the serum samples collected in all rounds of serological surveys.DiscussionThe population based sero-epidemiological studies will help to determine the burden of COVID-19 at the community level in urban and rural Indian populations and guide in monitoring the trends in the transmission of SARS-CoV-2 infection. Risk factors for infection will be identified to inform future control strategies. The serial serological surveys in the same set of participants will help determine the viral transmission dynamics and durability of neutralizing immune response in participants with or without symptomatic COVID infection.

India's quarterly GDP was estimated to grow by 8.4 percent in the second quarter of financial year 2022 compared to the same quarter in the previous fiscal year. While continuing to be a positive change, it was a significant reduction from the performance during the first quarter of fiscal year 2022 when GDP growth peaked by 20 percent.

Cost of the pandemic

As a result of the various lockdowns enforced since the onset of the coronavirus pandemic in 2020, the Indian economy has been reeling from a multibillion dollar setback. The GDP contribution as well as the employment rate among most major sectors, especially services and trade, had taken a hit. The agriculture sector was an exception, having experienced positive changes on both these fronts.

A slowly recovering economy

With the outbreak of the second wave of the pandemic in March 2021, the government redirected financial support to boost India’s vaccination campaign. As of February 2022, over a billion vaccine doses had been administered across the country. Furthermore, inflation within the country was expected to decline 2021 onwards. However, the stagnation of employment continued to remain a matter of concern with protests erupting across different states in 2022.

Approved COVID-19 Vaccines Market Outlook

The global market size for approved COVID-19 vaccines stood at approximately USD 45 billion in 2023 and is projected to reach around USD 78 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This substantial growth is primarily driven by continuous advancements in vaccine technology, increasing global vaccination drives, and the emergence of new variants necessitating booster doses.

One of the primary growth factors for the approved COVID-19 vaccines market is the ongoing need for booster vaccinations. As new variants of the virus emerge, vaccine manufacturers are continuously enhancing existing vaccines to tackle these variants effectively. This continuous innovation ensures sustained demand for updated vaccines, thereby propelling market growth. Additionally, governments worldwide are investing heavily in vaccination programs to achieve herd immunity, further boosting market size. Initiatives like COVAX, which aim to provide equitable vaccine access, are also significant contributors to market expansion.

Another crucial factor driving market growth is the increased awareness and acceptance of vaccines among the global population. Intensive public health campaigns and educational movements have led to a higher acceptance rate of vaccines, reducing vaccine hesitancy. This trend is particularly significant in emerging economies where initial vaccine skepticism was high. The successful roll-out of initial vaccine doses has built public confidence, thereby increasing the uptake of booster doses and new vaccine variants.

The collaboration between pharmaceutical companies and governments has also played a pivotal role in the growth of the COVID-19 vaccines market. Strategic partnerships for vaccine production, distribution, and administration have streamlined the supply chain, making vaccines more accessible to the public. These collaborations have also facilitated bulk purchasing agreements, which have provided cost advantages and enhanced market penetration across various regions. Moreover, the establishment of new manufacturing facilities and the expansion of existing ones have significantly accelerated vaccine production capabilities.

The development of the COVID-19 RNA Vaccine has been a groundbreaking advancement in the fight against the pandemic. Unlike traditional vaccines, RNA vaccines work by introducing a small piece of genetic material from the virus into the body, prompting an immune response without using a live virus. This innovative approach has allowed for rapid development and deployment, significantly contributing to the global vaccination efforts. The flexibility of RNA technology also enables quick updates to the vaccine to address new variants, ensuring continued protection as the virus evolves. This adaptability has made RNA vaccines a crucial tool in achieving widespread immunity and controlling the spread of COVID-19.

Regionally, North America leads the market due to its advanced healthcare infrastructure and early adoption of vaccination programs. Europe follows closely, with significant contributions from countries like Germany, France, and the UK. The Asia Pacific region is witnessing rapid growth, driven by substantial investments in healthcare infrastructure and large-scale vaccination drives in countries like India and China. Meanwhile, Latin America and the Middle East & Africa are gradually catching up, supported by international aid and improving healthcare systems. The regional diversity ensures a balanced growth outlook for the global market.

Vaccine Type Analysis

The market for approved COVID-19 vaccines is segmented into various types, including mRNA vaccines, vector vaccines, protein subunit vaccines, inactivated vaccines, and others. mRNA vaccines, such as those developed by Pfizer-BioNTech and Moderna, have gained significant traction due to their high efficacy rates and the rapid speed of development. The flexibility of mRNA technology to adapt swiftly to new variants has positioned them as a frontrunner in the market. This segment is expected to continue its dominance, supported by ongoing research and development activities aimed at enhancing vaccine formulations and delivery mechanisms.

Vector vaccines, which use a modified virus to deliver genetic material into cells, represent another significant segment. AstraZeneca and Johnson & Johnson are key players in t